Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection

BACKGROUND: At onset of coronavirus disease 2019 (COVID-19) pandemic, hydroxychloroquine (HCQ) was repurposed for treatment of patients based on reports that it had in vitro activity. The aim of this study was to find out if HCQ reduces number of days of hospitalization when given to patients with m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Med J Armed Forces India
Asıl Yazarlar: Gupta, Salil, Dixit, Prashant Kumar, Ghana, Parthasarathi, Abhisheka, Kumar, Khurana, Harshit, Jha, Vijoy Kumar, Mahapatra, Debasish, Goel, Jitesh, Ahmed, Safia, Varadaraj, G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313076/
https://ncbi.nlm.nih.gov/pubmed/34334898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.02.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller